Related Experiment Videos
Epstein-Barr virus suppresses a G(2)/M checkpoint activated by genotoxins
1Section of Virology and Cell Biology and Ludwig Institute for Cancer Research, Imperial College of Science Technology and Medicine, London W2 1PG, United Kingdom.
Abstract:
Several Epstein-Barr virus (EBV)-negative Burkitt lymphoma-derived cell lines (for example, BL41 and Ramos) are extremely sensitive to genotoxic drugs despite being functionally null for the tumor suppressor p53. They rapidly undergo apoptosis, largely from G(2)/M of the cell cycle. 5-bromo-2'-deoxyuridine labeling experiments showed that although the treated cells can pass through S phase, they are unable to complete cell division, suggesting that a G(2)/M checkpoint is activated. Surprisingly, latent infection of these genotoxin-sensitive cells with EBV protects them from both apoptosis and cell cycle arrest, allowing them to complete the division cycle. However, a comparison with EBV-immortalized B-lymphoblastoid cell lines (which have functional p53) showed that EBV does not block apoptosis per se but rather abrogates the activation of, or signalling from, the checkpoint in G(2)/M. Furthermore, analyses of BL41 and Ramos cells latently infected with P3HR1 mutant virus, which expresses only a subset of the latent viral genes, showed that LMP-1, the main antiapoptotic latent protein encoded by EBV, is not involved in the protection afforded here by viral infection. This conclusion was confirmed by analysis of clones of BL41 stably expressing LMP-1 from a transfected plasmid, which respond like the parental cell line. Although steady-state levels of Bcl-2 and related proteins varied between BL41 lines and clones, they did not change significantly during apoptosis, nor was the level of any of these anti- or proapoptotic proteins predictive of the outcome of treatment. We have demonstrated that a subset of EBV latent gene products can inactivate a cell cycle checkpoint for monitoring the fidelity and timing of cell division and therefore genomic integrity. This is likely to be important in EBV-associated growth transformation of B cells and perhaps tumorigenesis. Furthermore, this study suggests that EBV will be a unique tool for investigating the intimate relationship between cell cycle regulation and apoptosis.
Insights
Epstein-Barr virus (EBV) infection protects p53-null Burkitt lymphoma cells from genotoxic drugs by inactivating the G(2)/M cell cycle checkpoint, not by blocking apoptosis directly.
Area of Science:
- Virology
- Cell Biology
- Cancer Research
Background:
- Epstein-Barr virus (EBV)-negative Burkitt lymphoma cell lines lacking functional p53 are sensitive to genotoxic drugs.
- These cells undergo apoptosis and cell cycle arrest at G(2)/M.
- Latent EBV infection confers resistance to genotoxic agents in these cells.
Purpose of the Study:
- To investigate how latent EBV infection protects genotoxin-sensitive Burkitt lymphoma cells from apoptosis and cell cycle arrest.
- To determine the role of EBV latent genes, particularly LMP-1, in this protective mechanism.
- To elucidate the impact of EBV on cell cycle checkpoints and genomic integrity.
Main Methods:
- Genotoxic drug treatment of EBV-negative and latently EBV-infected Burkitt lymphoma cell lines (BL41, Ramos).
- 5-bromo-2'-deoxyuridine labeling to assess cell cycle progression.
- Analysis of cells infected with a mutant EBV (P3HR1) lacking certain latent genes.
- Stable expression of EBV's LMP-1 protein in BL41 cells.
- Western blot analysis of Bcl-2 family proteins.
Main Results:
- Latent EBV infection protects p53-null Burkitt lymphoma cells from genotoxic drug-induced apoptosis and G(2)/M arrest.
- EBV abrogates the G(2)/M checkpoint activation or signaling, rather than blocking apoptosis directly.
- The primary antiapoptotic EBV latent protein, LMP-1, is not responsible for this protection.
- Bcl-2 family protein levels did not correlate with the protective outcome.
Conclusions:
- A subset of EBV latent gene products inactivates the G(2)/M cell cycle checkpoint, preserving genomic integrity.
- This mechanism is likely crucial for EBV-driven B cell transformation and tumorigenesis.
- EBV serves as a valuable tool for studying cell cycle regulation and apoptosis interplay.